As of April 29, 2025, AN2 Therapeutics (ANTX) has a market cap of $36.720 million USD. According to our data, AN2 Therapeutics is ranked No.8286 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $36.72 M |
-10.94%
|
Dec 31, 2024 | $41.23 M |
-93.27%
|
Dec 29, 2023 | $0.61 B |
115.01%
|
Dec 30, 2022 | $0.28 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Vir Biotechnology
VIR
|
$0.83 B |
-0.000 M
|
![]() USA
|
![]() Arvinas
ARVN
|
$0.64 B |
-0.000 M
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$127.64 B |
0.004 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$132.39 B |
-0.001 M
|
![]() USA
|
![]() Biogen
BIIB
|
$17.59 B |
0.000 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$62.20 B |
1.034 B
|
![]() USA
|
![]() Moderna
MRNA
|
$10.76 B |
0.000 M
|
![]() USA
|
![]() Sarepta Therapeutics
SRPT
|
$5.98 B |
0.000 M
|
![]() USA
|
![]() Exelixis
EXEL
|
$10.62 B |
0.000 M
|
![]() USA
|
![]() Incyte
INCY
|
$11.69 B |
0.000 M
|
![]() USA
|
![]() Novavax
NVAX
|
$1.03 B |
0.000 M
|
![]() USA
|
![]() Amgen
AMGN
|
$152.20 B |
0.126 B
|
![]() USA
|
![]() Alkermes
ALKS
|
$4.74 B |
0.000 M
|
![]() Ireland
|
![]() Pfizer
PFE
|
$130.73 B |
-0.001 M
|
![]() USA
|
Market Cap | = | ANTX Stock Price | * | ANTX Shares Outstanding |
= | $1.22 | * | 30.10 M | |
= | $36.72 M |